K-beauty firms expand into devices and medical aesthetics
Korean beauty brands are broadening beyond makeup and skincare into beauty devices and medical-aesthetic offerings. The move aims to turn cosmetic firms into comprehensive beauty solution providers, but it faces regulatory standards, distributor requirements, and higher operating costs in overseas markets.
What changed and why it matters
Several major Korean beauty players are expanding into devices and aesthetic services. APR is developing focused-ultrasound devices and a polynucleotide-based skin booster. Amorepacific and PharmaResearch are pursuing device partnerships and broader medical-aesthetic offerings. Device makers such as Wontech and Classys are entering the home-beauty market. This shift could broaden product lines and revenue, but regulatory approvals and export costs create hurdles.
Key facts you should know
APR plans to launch a focused-ultrasound device and a polynucleotide skin booster. The polynucleotide booster has Class II medical device clearance and export approval from Korea’s food and drug regulator. Regulatory standards, distributor requirements, and higher costs are noted as challenges for overseas expansion.
Who is affected
Consumers may see new device options and combined beauty solutions from major Korean brands. Businesses in the supply chain—manufacturers of beauty devices, regulatory affairs teams, and distributors—face stricter rules and potential cost increases with cross-border sales. Employees working on research, development, and regulatory approvals may experience shifting priorities as firms push into medical-aesthetic products.
Practical next steps
For consumers: monitor product announcements from APR, Amorepacific, and partner firms for new devices and aesthetic services. For investors/partners: review regulatory timelines (Class II vs Class IV clearance) and export requirements in target markets (Japan, Middle East). For industry watchers: note that home-beauty devices are expanding, which may affect pricing, safety guidelines, and after-sales support. Regulatory bodies will continue to govern device approvals and cross-border sales, so expect updates on compliance procedures.
Which sources did Setup in Bahrain review?
Setup in Bahrain reviewed the following source material before preparing this explanatory article.
The links remain visible so readers can inspect the evidence, compare dates and context, and confirm current requirements with the relevant authority.
- koreatimes.co.kr — evidence source reviewed for this article.
Information and responsibility notice: This article is general information based on the cited material available when published. It is not legal, tax, immigration, medical, financial, banking, or investment advice; it does not create a professional-client relationship; and it is not a guarantee of outcome, availability, accuracy, or eligibility. Rules, schedules, prices, and third-party information can change. Confirm material decisions with the relevant authority and an appropriately qualified adviser before acting.